Efficacy of Valproate in Peripheral Neuropathic Pain

• Status: Terminated
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether valproate is effective and well tolerated in the treatment of neuropathic peripheral pain. The drug is administered by intravenous route followed by oral route during 4 weeks.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Bordeaux
• Collaborator: Sanofi-Synthelabo
• Treatments: Valproic Acid

Criteria

Inclusion Criteria:

• peripheral neuropathic pain

• signed written informed consent

Exclusion Criteria:

• central neuropathic pain

• current or past hepatic disease